APO RESEARCH · REPORT
Human Organs-on-Chips
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Product & engineering
Understand the product.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Selected research
Industry Research
Human Organs-on-Chips Industry Research Report 2026
Market perspective
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Read the full market overview
Global key players of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, Liver-on-a-chip is the largest segment, with a share over 28%. In terms of End User, Academic & Research Institutes is the largest market, with a share over 40%.
Report Scope
This report quantifies the global Human Organs-on-Chips market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Human Organs-on-Chips Market by Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Human Organs-on-Chips Segment by Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Human Organs-on-Chips Segment by End User
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Human Organs-on-Chips Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Organs-on-Chips market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Organs-on-Chips and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Organs-on-Chips.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Human Organs-on-Chips manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Human Organs-on-Chips by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Human Organs-on-Chips in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Applications
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
Companies covered
- Emulate
- TissUse
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Human Organs-on-Chips Market Size (2021-2032)
- 2.2.2 Global Human Organs-on-Chips Sales (2021-2032)
- 2.2.3 Global Human Organs-on-Chips Market Average Price (2021-2032)
- 2.3 Human Organs-on-Chips by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Brain-on-a-chip
- 2.3.3 Liver-on-a-chip
- 2.3.4 Kidney-on-a-chip
- 2.3.5 Lung-on-a-chip
- 2.3.6 Heart-on-a-chip
- 2.3.7 Intestine-on-a-chip
- 2.3.8 Vessel-on-a-chip
- 2.3.9 Other Organs
- 2.4 Human Organs-on-Chips by End User
- 2.4.1 Market Value Comparison by End User (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical & Biotechnology Companies
- 2.4.3 Academic & Research Institutes
- 2.4.4 Cosmetics Industry
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Human Organs-on-Chips Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Human Organs-on-Chips Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Human Organs-on-Chips Revenue of Manufacturers (2021-2026)
- 3.4 Global Human Organs-on-Chips Average Price by Manufacturers (2021-2026)
- 3.5 Global Human Organs-on-Chips Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Human Organs-on-Chips, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Human Organs-on-Chips, Product Type & Application
- 3.8 Global Manufacturers of Human Organs-on-Chips, Established Date
- 3.9 Global Human Organs-on-Chips Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Emulate
- 4.1.1 Emulate Company Information
- 4.1.2 Emulate Business Overview
- 4.1.3 Emulate Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Emulate Human Organs-on-Chips Product Portfolio
- 4.1.5 Emulate Recent Developments
- 4.2 TissUse
- 4.2.1 TissUse Company Information
- 4.2.2 TissUse Business Overview
- 4.2.3 TissUse Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 TissUse Human Organs-on-Chips Product Portfolio
- 4.2.5 TissUse Recent Developments
- 4.3 Hesperos
- 4.3.1 Hesperos Company Information
- 4.3.2 Hesperos Business Overview
- 4.3.3 Hesperos Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hesperos Human Organs-on-Chips Product Portfolio
- 4.3.5 Hesperos Recent Developments
- 4.4 CN Bio Innovations
- 4.4.1 CN Bio Innovations Company Information
- 4.4.2 CN Bio Innovations Business Overview
- 4.4.3 CN Bio Innovations Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CN Bio Innovations Human Organs-on-Chips Product Portfolio
- 4.4.5 CN Bio Innovations Recent Developments
- 4.5 Tara Biosystems
- 4.5.1 Tara Biosystems Company Information
- 4.5.2 Tara Biosystems Business Overview
- 4.5.3 Tara Biosystems Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tara Biosystems Human Organs-on-Chips Product Portfolio
- 4.5.5 Tara Biosystems Recent Developments
- 4.6 Draper Laboratory
- 4.6.1 Draper Laboratory Company Information
- 4.6.2 Draper Laboratory Business Overview
- 4.6.3 Draper Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Draper Laboratory Human Organs-on-Chips Product Portfolio
- 4.6.5 Draper Laboratory Recent Developments
- 4.7 Mimetas
- 4.7.1 Mimetas Company Information
- 4.7.2 Mimetas Business Overview
- 4.7.3 Mimetas Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mimetas Human Organs-on-Chips Product Portfolio
- 4.7.5 Mimetas Recent Developments
- 4.8 Nortis
- 4.8.1 Nortis Company Information
- 4.8.2 Nortis Business Overview
- 4.8.3 Nortis Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nortis Human Organs-on-Chips Product Portfolio
- 4.8.5 Nortis Recent Developments
- 4.9 Micronit Microtechnologies B.V.
- 4.9.1 Micronit Microtechnologies B.V. Company Information
- 4.9.2 Micronit Microtechnologies B.V. Business Overview
- 4.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Product Portfolio
- 4.9.5 Micronit Microtechnologies B.V. Recent Developments
- 4.10 Kirkstall
- 4.10.1 Kirkstall Company Information
- 4.10.2 Kirkstall Business Overview
- 4.10.3 Kirkstall Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kirkstall Human Organs-on-Chips Product Portfolio
- 4.10.5 Kirkstall Recent Developments
- 4.11 Cherry Biotech SAS
- 4.11.1 Cherry Biotech SAS Company Information
- 4.11.2 Cherry Biotech SAS Business Overview
- 4.11.3 Cherry Biotech SAS Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Cherry Biotech SAS Human Organs-on-Chips Product Portfolio
- 4.11.5 Cherry Biotech SAS Recent Developments
- 4.12 Else Kooi Laboratory
- 4.12.1 Else Kooi Laboratory Company Information
- 4.12.2 Else Kooi Laboratory Business Overview
- 4.12.3 Else Kooi Laboratory Human Organs-on-Chips Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Else Kooi Laboratory Human Organs-on-Chips Product Portfolio
- 4.12.5 Else Kooi Laboratory Recent Developments
5 Global Human Organs-on-Chips Market Scenario by Region
- 5.1 Global Human Organs-on-Chips Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Human Organs-on-Chips Sales by Region: 2021-2032
- 5.2.1 Global Human Organs-on-Chips Sales by Region: 2021-2026
- 5.2.2 Global Human Organs-on-Chips Sales by Region: 2027-2032
- 5.3 Global Human Organs-on-Chips Revenue by Region: 2021-2032
- 5.3.1 Global Human Organs-on-Chips Revenue by Region: 2021-2026
- 5.3.2 Global Human Organs-on-Chips Revenue by Region: 2027-2032
- 5.4 North America Human Organs-on-Chips Market Facts & Figures by Country
- 5.4.1 North America Human Organs-on-Chips Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Human Organs-on-Chips Sales by Country (2021-2032)
- 5.4.3 North America Human Organs-on-Chips Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Human Organs-on-Chips Market Facts & Figures by Country
- 5.5.1 Europe Human Organs-on-Chips Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Human Organs-on-Chips Sales by Country (2021-2032)
- 5.5.3 Europe Human Organs-on-Chips Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Human Organs-on-Chips Market Facts & Figures by Country
- 5.6.1 Asia Pacific Human Organs-on-Chips Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Human Organs-on-Chips Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Human Organs-on-Chips Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Human Organs-on-Chips Market Facts & Figures by Country
- 5.7.1 South America Human Organs-on-Chips Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Human Organs-on-Chips Sales by Country (2021-2032)
- 5.7.3 South America Human Organs-on-Chips Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Human Organs-on-Chips Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Human Organs-on-Chips Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Human Organs-on-Chips Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Human Organs-on-Chips Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Human Organs-on-Chips Sales by Type (2021-2032)
- 6.1.1 Global Human Organs-on-Chips Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Human Organs-on-Chips Sales Market Share by Type (2021-2032)
- 6.2 Global Human Organs-on-Chips Revenue by Type (2021-2032)
- 6.2.1 Global Human Organs-on-Chips Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Human Organs-on-Chips Revenue Market Share by Type (2021-2032)
- 6.3 Global Human Organs-on-Chips Price by Type (2021-2032)
7 Segment by End User
- 7.1 Global Human Organs-on-Chips Sales by End User (2021-2032)
- 7.1.1 Global Human Organs-on-Chips Sales by End User (2021-2032) & (K Units)
- 7.1.2 Global Human Organs-on-Chips Sales Market Share by End User (2021-2032)
- 7.2 Global Human Organs-on-Chips Revenue by End User (2021-2032)
- 7.2.1 Global Human Organs-on-Chips Sales by End User (2021-2032) & (US$ Million)
- 7.2.2 Global Human Organs-on-Chips Revenue Market Share by End User (2021-2032)
- 7.3 Global Human Organs-on-Chips Price by End User (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Human Organs-on-Chips Value Chain Analysis
- 8.1.1 Human Organs-on-Chips Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Human Organs-on-Chips Production Mode & Process
- 8.2 Human Organs-on-Chips Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Human Organs-on-Chips Distributors
- 8.2.3 Human Organs-on-Chips Customers
9 Global Human Organs-on-Chips Analyzing Market Dynamics
- 9.1 Human Organs-on-Chips Industry Trends
- 9.2 Human Organs-on-Chips Industry Drivers
- 9.3 Human Organs-on-Chips Industry Opportunities and Challenges
- 9.4 Human Organs-on-Chips Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst